Treatment of Lyme arthritis after oral antibiotics have not resolved joint swelling

Lyme arthritis — joint swelling driven by Lyme disease — typically responds to an initial course of oral antibiotic therapy. When it does not, a structured next-line approach is indicated.

Clinical scenario

Lyme arthritis with persistent or inadequately resolving joint swelling despite completing a course of oral antibiotic therapy.

Previous line & failure condition

The first-line approach for Lyme arthritis is oral antibiotic therapy for 28 days — using doxycycline, amoxicillin, or cefuroxime axetil. The expected outcome is resolution of arthritis within 1–3 months.

When joint swelling shows no or minimal reduction beyond that window, escalation to this next-line protocol is indicated.

Next-line approach (partial)

When oral antibiotic therapy proves insufficient, intravenous antibiotic therapy is the recommended next step, with the course length adjusted based on the degree of response.

Goal: resolution of all signs and symptoms of arthritis (joint swelling) — which may take many months to over a year.

Instant Access to Structured Evidence-Based Regimens

References

For patients with Lyme arthritis, we recommend using oral antibiotic therapy for 28 days (strong recommendation, moderate-quality evidence).
In patients with Lyme arthritis with no or minimal response (moderate to severe joint swelling with minimal reduction of the joint effusion) to an initial course of oral antibiotic, we suggest a 2- to 4-week course of IV ceftriaxone over a second course of oral antibiotics (weak recommendation, low-quality evidence).
We suggest a 2-week course of IV ceftriaxone that can be extended to 4 weeks if resolution is not complete.
Patients who are treated with IV ceftriaxone for Lyme arthritis have resolution of all signs and symptoms in 59–83% of cases, although complete resolution may take many months to over a year.

View source ↗